Learn More

Offer GLP-1 Access Without Waiting for Your PBM

Give your employees affordable access to clinically-proven weight loss medications through a simple voluntary program — no PBM contract changes required.
Get Started Today
$0
cost to your company

Four steps. That's it.

01
Sign the Agreement
Complete a simple digital authorization — no cost to your company.
02
Members stay in the program beyond six months
We generate unique discount codes for your employees within 24 hours.
03
Average weight lost in six months
Distribute codes via email, intranet, or benefits portal — your choice.
04
Average weight lost in six months
Employees use their code to access discounted GLP-1 medications at $149.99/month.
Get Started Today

You're already paying for obesity.

Through insurance premiums, sick days, and lost productivity. A clinically supervised GLP-1 program addresses the root cause — and pays for itself.

$
excess cost per employee with obesity, per year

2x

Lower your healthcare costs

Employees with obesity cost 2x more in medical claims. GLP-1 users show 7% lower costs within 18 months and 44% fewer cardiovascular events.

43%

Boost Retention

of large employers now cover GLP-1s. Offering this benefit signals you invest in employee wellbeing — a top driver of retention.

$0

Zero Risk to you

Voluntary, employee-paid program. No cost to your organization, no PBM changes, no disruption to existing benefits.

The New Wegovy® Pill

Powerful results with just one pill a day

FDA approved for weight loss and cardiovascular risk reduction
Up to 15% body weight loss in clinical trials
Injection-free, just one pill a day, no refrigeration
Same proven ingredient as the injection (semaglutide)

“High-quality medical care should be accessible to everyone, across different life stages, health goals, and needs.”

Tom Brady
eMed, Chief Wellness Officer

Step towards healthier employees and more predictable costs.

This form is for organizations, brokers, and benefits leaders exploring eMed’s Population Health GLP-1 solutions for employers.
Arrow Navbar
Thank you! Your submission has been received!
Return to homepage
Oops! Something went wrong while submitting the form, please try again

Solutions
About
Blood Test
In the news
Careers
Resources
Support
FAQ
Blog
Connect
Privacy Policy | Terms of Use | Notice of Privacy Practices | Biometric Data Privacy Policy  | Consumer Health Data Privacy Notice | Florida Patients | UK Operations  
© 2026 eMed® All rights reserved. The products of eMed are protected by patents.
Wegovy ® is a registered trademark of Novo Nordisk A/S.
Zepbound® and KwikPen® are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

All other trademarks, registered or unregistered, are the property of their respective owners.
Prescriptions for medication subject to a consultation with a licensed clinician. Not all persons may be eligible or qualify to receive a prescribed treatment.
Verify Approval for www.emed.com